Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 4.52% is 45% below its 5-year average of 8.22%, around the middle of its 5-year range (-6.60%–14.35%).
16.39% below its 12-month average of 5.41%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): 7.57%.
NET PROFIT MARGIN
4.52%
NET PROFIT MARGIN AVG TTM
5.41%
NET PROFIT MARGIN AVG 3Y
7.46%
NET PROFIT MARGIN AVG 5Y
8.22%
NET PROFIT MARGIN AVG 10Y
7.37%
NET PROFIT MARGIN AVG 15Y
8.90%
NET PROFIT MARGIN AVG 20Y
10.70%
CURRENT VS TTM AVG
-16.39%
CURRENT VS 3Y AVG
-39.42%
CURRENT VS 5Y AVG
-45.03%
CURRENT VS 10Y AVG
-38.68%
CURRENT VS 15Y AVG
-49.23%
CURRENT VS 20Y AVG
-57.74%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-50.90%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$49.00B
Net Profit Margin
4.52%
TTM Avg
5.41%
3Y Avg
7.46%
5Y Avg
8.22%
Market Cap
$48.58B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
Market Cap
$43.20B
Net Profit Margin
4.08%
TTM Avg
-0.87%
3Y Avg
-5.42%
5Y Avg
-7.16%
Market Cap
$43.09B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$54.94B
Net Profit Margin
0.67%
TTM Avg
0.69%
3Y Avg
0.48%
5Y Avg
0.29%
Market Cap
$41.50B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$57.13B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$39.81B
Net Profit Margin
25.03%
TTM Avg
23.70%
3Y Avg
22.66%
5Y Avg
22.55%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Becton, Dickinson and Company (BDX) | $49.00B | 4.52% | 5.41% | 7.46% | 8.22% |
| Humana Inc. (HUM)vs › | $49.21B | 0.88% | 0.97% | 1.82% | 2.53% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 15.43% | 47.22% | 37.68% | 33.03% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 4.08% | -0.87% | -5.42% | -7.16% |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 8.10% | 8.63% | 8.47% | 7.22% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 0.67% | 0.69% | 0.48% | 0.29% |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 19.53% | 19.27% | 18.75% | 17.94% |
| Moderna, Inc. (MRNA)vs › | $57.13B | -141.43% | -128.24% | -70.25% | -50.87% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $39.81B | 25.03% | 23.70% | 22.66% | 22.55% |
| Cencora, Inc. (COR)vs › | $62.57B | 0.79% | 0.49% | 0.59% | 0.22% |
Operating Margin
9.8%
Net Profit Margin
4.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.57% |
| 2026-03-31 | -6.60% |
| 2025-12-31 | 7.27% |
| 2025-09-30 | 8.37% |
| 2025-06-30 | 10.42% |
| 2025-03-31 | 5.84% |
| 2024-12-31 | 5.86% |
| 2024-09-30 | 7.36% |
| 2024-06-30 | 9.76% |
| 2024-03-31 | 10.64% |
| 2023-12-31 | 5.97% |
| 2023-09-30 | 2.12% |
| 2023-06-30 | 8.34% |
| 2023-03-31 | 9.54% |
| 2022-12-31 | 11.10% |
| 2022-09-30 | 6.05% |
| 2022-06-30 | 7.76% |
| 2022-03-31 | 9.56% |
| 2021-12-31 | 14.35% |
| 2021-09-30 | 5.16% |
| 2021-06-30 | 11.40% |
| 2021-03-31 | 6.09% |
| 2020-12-31 | 18.87% |
| 2020-09-30 | 2.68% |
| 2020-06-30 | 7.42% |
| 2020-03-31 | 4.30% |
| 2019-12-31 | 6.58% |
| 2019-09-30 | 3.53% |
| 2019-06-30 | 10.37% |
| 2019-03-31 | 0.48% |
| 2018-12-31 | 14.40% |
| 2018-09-30 | -3.07% |
| 2018-06-30 | 13.88% |
| 2018-03-31 | -0.28% |
| 2017-12-31 | -4.42% |
| 2017-09-30 | 10.33% |
| 2017-06-30 | -4.35% |
| 2017-03-31 | 11.59% |
| 2016-12-31 | 19.23% |
| 2016-09-30 | 0.59% |
| 2016-06-30 | 12.20% |
| 2016-03-31 | 11.02% |
| 2015-12-31 | 7.67% |
| 2015-09-30 | 5.92% |
| 2015-06-30 | 1.99% |
| 2015-03-31 | 10.53% |
| 2014-12-31 | 11.51% |
| 2014-09-30 | 13.67% |
| 2014-06-30 | 15.11% |
| 2014-03-31 | 13.85% |
| 2013-12-31 | 13.45% |
| 2013-09-30 | 4.30% |
| 2013-06-30 | 14.71% |
| 2013-03-31 | 13.80% |
| 2012-12-31 | 32.89% |
| 2012-09-30 | 14.69% |
| 2012-06-30 | 16.50% |
| 2012-03-31 | 15.09% |
| 2011-12-31 | 14.36% |
| 2011-09-30 | 14.63% |
| 2011-06-30 | 17.58% |
| 2011-03-31 | 16.23% |
| 2010-12-31 | 17.15% |
| 2010-09-30 | 22.90% |
| 2010-06-30 | 16.76% |
| 2010-03-31 | 16.54% |
| 2009-12-31 | 16.93% |
| 2009-09-30 | 16.72% |
| 2009-06-30 | 18.74% |
| 2009-03-31 | 15.15% |
| 2008-12-31 | 18.17% |
| 2008-09-30 | 15.37% |
| 2008-06-30 | 15.91% |
| 2008-03-31 | 15.81% |
| 2007-12-31 | 15.92% |
| 2007-09-30 | 15.74% |
| 2007-06-30 | 15.01% |
| 2007-03-31 | 15.39% |
| 2006-12-31 | 9.52% |
| 2006-09-30 | 11.69% |
| 2006-06-30 | 14.16% |
| 2006-03-31 | 10.82% |
| 2005-12-31 | 15.63% |
| 2005-09-30 | 10.81% |
| 2005-06-30 | 13.73% |
| 2005-03-31 | 13.78% |
| 2004-12-31 | 15.16% |
| 2004-09-30 | 5.59% |
| 2004-06-30 | 8.80% |
| 2004-03-31 | 13.17% |
| 2003-12-31 | 10.58% |
| 2003-09-30 | 13.71% |
| 2003-06-30 | 11.16% |
| 2003-03-31 | 12.53% |
| 2002-12-31 | 10.81% |
| 2002-09-30 | 12.20% |
